BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Dührsen L, Hartfuß S, Hirsch D, et al. (2019) Preclinical analysis of human mesenchymal stem cells: tumor tropism and therapeutic efficiency of local HSV-TK suicide gene therapy in glioblastoma. Oncotarget. 10: 6049-6061 |
| Geiger S, Ozay EI, Geumann U, et al. (2019) Alpha-1 Antitrypsin-Expressing Mesenchymal Stromal Cells Confer a Long-Term Survival Benefit in a Mouse Model of Lethal GvHD. Molecular Therapy : the Journal of the American Society of Gene Therapy |
| Urbinati F, Wherley J, Geiger S, et al. (2017) Preclinical studies for a phase 1 clinical trial of autologous hematopoietic stem cell gene therapy for sickle cell disease. Cytotherapy |
| Geiger S, Hirsch D, Hermann FG. (2017) Cell therapy for lung disease. European Respiratory Review : An Official Journal of the European Respiratory Society. 26 |
| Shaw KL, Garabedian E, Mishra S, et al. (2017) Clinical efficacy of gene-modified stem cells in adenosine deaminase-deficient immunodeficiency. The Journal of Clinical Investigation |
| Urbinati F, Hargrove PW, Geiger S, et al. (2015) Potentially therapeutic levels of anti-sickling globin gene expression following lentivirus-mediated gene transfer in sickle cell disease bone marrow CD34+ cells. Experimental Hematology. 43: 346-51 |
| Carbonaro-Sarracino DA, Kaufman ML, Jin X, et al. (2015) 442. Decreased Survival and Engraftment in Adult ADA-Deficient Mice Co-Transplanted With Uncorrected Lineage-Positive Bone Marrow Cells Combined With Gene-Corrected Lineage-Negative Bone Marrow Cells Molecular Therapy. 23 |
| Shaw KL, Garabedian E, Sokolic R, et al. (2015) 30. Phase II Clinical Trial of Gene Therapy for Adenosine Deaminase-Deficient Severe Combined Immune Deficiency (ADA-SCID) Using a γ-Retroviral Vector Molecular Therapy. 23 |
| Carbonaro Sarracino D, Tarantal AF, Lee CC, et al. (2014) Effects of vector backbone and pseudotype on lentiviral vector-mediated gene transfer: studies in infant ADA-deficient mice and rhesus monkeys. Molecular Therapy : the Journal of the American Society of Gene Therapy. 22: 1803-16 |
| Carbonaro DA, Zhang L, Jin X, et al. (2014) Preclinical demonstration of lentiviral vector-mediated correction of immunological and metabolic abnormalities in models of adenosine deaminase deficiency. Molecular Therapy : the Journal of the American Society of Gene Therapy. 22: 607-22 |